In conclusion, the shift in the balance of Th1 and Th2 CK expression indicates higher tumor invasiveness, and IFN has potential as a circulating molecular marker for immunotherapy of head and neck squamous cell carcinoma. Here, IFNA1 is linked to head and neck squamous cell carcinoma.